AstraZeneca issues Crestor safety warning
May 20, 2004AstraZeneca has written to healthcare professionals in the UK after a small number of patients reported serious side effects after …
Addressing the gender divide
May 20, 2004A recent report by the Equal Opportunity Commission (EOC), Promoting Gender Equality in Health, has highlighted a significant omission which …
GSK establishes strategic link with Theravance
May 20, 2004GlaxoSmithKline has paid $129 million to a small US biotech company for a three-year worldwide licensing option on all the …
European biotech revenues fall back
May 20, 2004Revenues from the European biotech sector have fallen back for the first time in 2003, as many companies across the …
Faslodex launched in UK
May 19, 2004AstraZeneca, Faslodex
The latest addition to AstraZeneca’s oncology franchise, breast cancer drug Faslodex has been launched in the UK.Licensed for the treatment …
Obesity drug collaboration for BMS and Solvay
May 19, 2004Bristol-Myers Squibb and Solvay are to collaborate on the development and marketing of a novel phase I compound for the …
NICE strikes deal with industry on data confidentiality
May 19, 2004The industry and NICE have reached agreement on how the cost and clinical effectiveness body can meet demands for transparency …
TNF-blockers continue to expand indications
May 14, 2004Competitors in one of the industry's fastest growing markets, the TNF-blocker class of rheumatoid arthritis drugs, have gained extensions to …
New laws to combat animal rights extremists
May 14, 2004New legislation will be introduced to combat animal rights extremists' violence against those involved in using animals in medical research.But …
GSK sued for ‘abandoning’ Relenza
May 14, 2004Biota, the Australian biotech company that discovered Relenza, is taking GlaxoSmithKline to court, alleging that it failed to properly launch …
Antisoma and Roche’s ovarian cancer drug disappoints
May 12, 2004A phase III trial of a drug to treat ovarian cancer has disappointed and is likely to be dropped, co-developers …
Intervention from Paris secures French future for Aventis
May 7, 2004Aventis has dropped its long-running opposition to a takeover bid by French compatriots Sanofi-Synthlabo after the offer to its shareholders …
OTC Zocor to be cleared but divisions persist
April 28, 2004The government is shortly to announce the approval of the world's first over-the-counter statin, Zocor Heart Pro, but is unlikely …
Burson-Marsteller to launch cancer treatment in the UK
April 28, 2004Burson-Marsteller, a subsidiary of the WPP advertising giant, has been appointed PR campaign handler for the UK launch of Velcade, …
Patients still being denied access to colon cancer treatments
April 28, 2004A new Roche-sponsored survey of patients with bowel cancer has found that most are still not being consulted on the …
